EZH2: a novel target for cancer treatment

Overview of attention for article published in Journal of Hematology & Oncology, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 60,229 followers.

RT @PSOGI_EC: Epithelioid variety is the most common subtype which can transform into other subtypes EZH2 is a therapeutic target seen all…

RT @PSOGI_EC: Epithelioid variety is the most common subtype which can transform into other subtypes EZH2 is a therapeutic target seen all…

RT @PSOGI_EC: Epithelioid variety is the most common subtype which can transform into other subtypes EZH2 is a therapeutic target seen all…

RT @PSOGI_EC: Epithelioid variety is the most common subtype which can transform into other subtypes EZH2 is a therapeutic target seen all…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.